Research classification: AECQS figures shown on this site are historical backtest and simulated research outputs unless explicitly identified otherwise. They are not audited live fund performance, investor returns, or a guarantee of future results. Nothing on this page is an offer to sell or solicitation to buy a security or investment product.
AECQS · Final 10-Entry Research Configuration
Current research evidence.
Net Backtest P&L
+$31,648,982.32
Historical simulation.
Accepted Trades
53,317
Historical research trades.
Research Markets
3
Current research checkpoint.
Max Entries / Market
10
Current research checkpoint.
Cross-Portfolio Max Drawdown
Not calculated
Market-level drawdowns are reported separately; no combined value is inferred.
Research Markets
NQ · ES · YM
Nasdaq-100, S&P 500 and Dow Jones E-mini futures research.
Program
Active R&D
System remains under development.
Classification
Simulation
Not audited live fund performance.
Development History
Research checkpoints, not a continuous investor track record.
7-Core
+$1,031,859Earlier core research checkpoint · PF/trade count/win rate not published here.10-Family
+$1,450,037PF 1.171 · 5,868 trades · 43.42% win rate.13-Entry
+$2,090,248.23PF 1.164 · 7,234 trades · 43.18% win rate.AECQS-30
+$6,039,476.17Earlier research checkpoint · PF 1.131 · 25,507 trades · 45.42% win rate.Final 10-Entry
+$31,648,982.32Raw combined historical backtest/simulated net P&L · 53,317 trades · NQ, ES and YM. Combined PF and cross-portfolio max DD not inferred.Comparability note: Checkpoints can differ in strategy universe, implementation, sizing, assumptions and portfolio construction. This documents research evolution; it is not a time-series return history of one unchanged portfolio.
Evidence Classification
Keep unlike evidence separate.
Historical Simulation
Backtest outputs generated from historical data under modeled strategy and execution assumptions.
Development Checkpoint
A snapshot of the system at a particular research state; later versions may materially change.
Executed Record
Actual executed trading should be reported separately and only when source records support the claim.
Interpretation
What these numbers do — and do not — establish.
They show
The output of the current historical research implementation under its modeled assumptions.
They can support
Comparison between research checkpoints and prioritization of further validation work.
They do not prove
Future profitability, live execution quality, investor returns or persistence in unseen markets.
Metrics Not Yet Published
No invented statistics.
Sharpe, Sortino, expectancy, rolling return distributions, strategy attribution, regime attribution and other advanced statistics should be added only after they are calculated from the underlying accepted-trade and equity-curve data using a documented methodology. This page intentionally does not estimate them from incomplete summary figures.